![1]()
News
Some HCV medications associated with serious liver injury
August 29, 2019
In many cases, the medications should never have been prescribed, according to the FDA.
![1]()
News
Additional physical therapy decreases length of stay
August 29, 2019
Does additional physical therapy reduce length of stay and improve outcomes?
![1]()
Article
Use hospital MRSA rates to guide pediatric osteomyelitis treatment
August 28, 2019
SEATTLE – If your hospital MRSA rate is less than 10%, cefazolin is a reasonable empiric choice for acute pediatric hematogenous osteomyelitis.
![1]()
News
Blood test may reveal brain injury
August 27, 2019
Levels of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1) are lowest in patients with nonconcussive body trauma, higher in patients with nonconcussive head trauma, and highest in patients with concussion.
![1]()
News
FDA’s low-risk TAVR okay set to propel case volume
August 27, 2019
The FDA’s approval of TAVR for low-risk patients should boost both case numbers and U.S. TAVR sites.
![1]()
News
CPAP safety for infants with bronchiolitis on the general pediatrics floor
August 26, 2019
SEATTLE – “Very, very few” hospitals do bronchiolitis CPAP outside of the ICU.
![1]()
News
Anticoagulant therapy for AFib in patients with end-stage renal disease
August 23, 2019
Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.
![1]()
News
FUO, pneumonia often distinguishes influenza from RSV in hospitalized young children
August 22, 2019
LJUBLJANA, SLOVENIA – “These findings open new possibilities for antimicrobial stewardship in these groups of virally infected children.” Dr. Cihan Papan.
![1]()
News
Treating children with Kawasaki disease and coronary enlargement
August 22, 2019
An important new study reveals a treatment protocol that decreases the rate of aneurysm enlargement.
News
Dapagliflozin meets primary endpoint in the DAPA-HF trial
August 21, 2019
AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.
